Business Description
Rossari Biotech Ltd
ISIN : INE02A801020
Share Class Description:
NSE:ROSSARI: Ordinary SharesTotal Employee Number:
1,268Compare
Compare
Traded in other countries / regions
543213.India Index Membership
NIFTY 500 IPO Date
2020-07-23Description
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | 1.41 | |||||
Interest Coverage | 7.24 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.95 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.1 | |||||
3-Year EBITDA Growth Rate | 10.5 | |||||
3-Year EPS without NRI Growth Rate | 8 | |||||
3-Year Book Growth Rate | 13.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.02 | |||||
9-Day RSI | 45.2 | |||||
14-Day RSI | 48.81 | |||||
3-1 Month Momentum % | 23.39 | |||||
6-1 Month Momentum % | -9.47 | |||||
12-1 Month Momentum % | -22.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 83.18 | |||||
Days Sales Outstanding | 79.83 | |||||
Days Payable | 65.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.1 | |||||
Dividend Payout Ratio | 0.02 | |||||
Forward Dividend Yield % | 0.1 | |||||
5-Year Yield-on-Cost % | 0.1 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -7.01 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.36 | |||||
Operating Margin % | 8.63 | |||||
Net Margin % | 6.23 | |||||
EBITDA Margin % | 12.94 | |||||
FCF Margin % | -8.33 | |||||
OCF Margin % | 2.72 | |||||
ROE % | 11.87 | |||||
ROA % | 7.14 | |||||
ROIC % | 9.1 | |||||
3-Year ROIIC % | 3.38 | |||||
ROC (Joel Greenblatt) % | 18.84 | |||||
ROCE % | 16.11 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.42 | |||||
Forward PE Ratio | 18.21 | |||||
PE Ratio without NRI | 19.42 | |||||
PEG Ratio | 1.27 | |||||
PS Ratio | 1.21 | |||||
PB Ratio | 2.17 | |||||
Price-to-Tangible-Book | 2.61 | |||||
Price-to-Operating-Cash-Flow | 44.5 | |||||
EV-to-EBIT | 13.93 | |||||
EV-to-EBITDA | 10.37 | |||||
EV-to-Revenue | 1.34 | |||||
EV-to-FCF | -16.12 | |||||
Price-to-GF-Value | 0.52 | |||||
Price-to-Projected-FCF | 4.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.42 | |||||
Price-to-Graham-Number | 1.5 | |||||
| Price-to-Net-Current-Asset-Value | 10.32 | |||||
Earnings Yield (Greenblatt) % | 7.18 | |||||
FCF Yield % | -6.9 | |||||
Forward Rate of Return (Yacktman) % | 14.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rossari Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 23,963.65 | ||
| EPS (TTM) (₹) | 26.91 | ||
| Beta | 1.7829 | ||
| 3-Year Sharpe Ratio | -0.53 | ||
| 3-Year Sortino Ratio | -0.71 | ||
| Volatility % | 42.82 | ||
| 14-Day RSI | 48.81 | ||
| 14-Day ATR (₹) | 18.107018 | ||
| 20-Day SMA (₹) | 523.845 | ||
| 12-1 Month Momentum % | -22.36 | ||
| 52-Week Range (₹) | 375 - 766 | ||
| Shares Outstanding (Mil) | 55.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rossari Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rossari Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-10-16 15:30 | In 103 days | ||
| Second quarter earnings results for 2027 | 2026-10-16 | In 102 days | ||
| First quarter earnings conference call for 2027 | 2026-07-21 16:00 | In 16 days | ||
| First quarter earnings results for 2027 | 2026-07-21 | In 15 days | ||
| General meeting for 2026 | 2026-07-20 11:00 | In 15 days | ||
| INR 0.500000 Cash Dividend | 2026-07-10 | In 4 days | ||
| Annual report for 2026 | 2026-06-27 | 534.85 (+0.00%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-04-28 17:00 | 504.20 (-3.22%) | ||
| Fourth quarter earnings results for 2026 | 2026-04-27 | 516.40 (+0.99%) | ||
| Third quarter earnings conference call for 2026 | 2026-01-19 16:00 | 534.75 (-0.42%) |
Show
Entries
Rossari Biotech Ltd Frequently Asked Questions
What is Rossari Biotech Ltd(NSE:ROSSARI)'s stock price today?
The current price of NSE:ROSSARI is ₹521.65. The 52 week high of NSE:ROSSARI is ₹766.00 and 52 week low is ₹375.00.
When is next earnings date of Rossari Biotech Ltd(NSE:ROSSARI)?
The next earnings date of Rossari Biotech Ltd(NSE:ROSSARI) is 2026-07-21 Est..
Does Rossari Biotech Ltd(NSE:ROSSARI) pay dividends? If so, how much?
The Dividend Yield %  of Rossari Biotech Ltd(NSE:ROSSARI) is 0.1% (As of Today), Highest Dividend Payout Ratio of Rossari Biotech Ltd(NSE:ROSSARI) was 0.03. The lowest was 0.02. And the median was 0.02. The  Forward Dividend Yield % of Rossari Biotech Ltd(NSE:ROSSARI) is 0.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Rossari Biotech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers